Aaron P. Jansen, Ph.D.
Affiliations: | 2000 | University of Wisconsin, Madison, Madison, WI |
Area:
Oncology, Cell BiologyGoogle:
"Aaron Jansen"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Ajit K. Verma | grad student | 2000 | UW Madison | |
| (Protein kinase C transgenic mice and skin carcinogenesis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Schmid T, Jansen AP, Baker AR, et al. (2008) Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion. Cancer Research. 68: 1254-60 |
| Jansen AP, Camalier CE, Colburn NH. (2005) Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Research. 65: 6034-41 |
| Jansen AP, Dreckschmidt NE, Verwiebe EG, et al. (2001) Relation of the induction of epidermal ornithine decarboxylase and hyperplasia to the different skin tumor-promotion susceptibilities of protein kinase C alpha, -delta and -epsilon transgenic mice. International Journal of Cancer. 93: 635-43 |
| Yang HS, Jansen AP, Nair R, et al. (2001) A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene. 20: 669-76 |
| Jansen AP, Verwiebe EG, Dreckschmidt NE, et al. (2001) Protein kinase C-epsilon transgenic mice: a unique model for metastatic squamous cell carcinoma. Cancer Research. 61: 808-12 |
| Jansen AP, Colburn NH, Verma AK. (1999) Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation. Oncogene. 18: 5806-13 |